- Home
- FLYX vs BDTX Comparison
FLYX vs BDTX Comparison
Compare FLYX & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLYX | BDTX |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.7M | 116.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FLYX | BDTX |
|---|---|---|
| Price | $2.26 | $2.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.20 |
| AVG Volume (30 Days) | 404.8K | ★ 591.0K |
| Earning Date | 03-04-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.71 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | $9.36 | N/A |
| Revenue Next Year | $15.14 | N/A |
| P/E Ratio | ★ N/A | $5.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $1.20 |
| 52 Week High | $8.88 | $4.94 |
Technical Indicators
Market Signals| Indicator | FLYX | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 43.15 |
| Support Level | $1.94 | $1.93 |
| Resistance Level | $2.73 | $2.86 |
| Average True Range (ATR) | 0.28 | 0.14 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 35.73 | 40.18 |
Price Performance
Historical ComparisonAbout FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.